Who owns Avalo Therapeutics, Inc.? Owners, funding and legal record

Before you sign or pay

• Court and bankruptcy: No federal court case or bankruptcy filing found under Avalo Therapeutics, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
• Leadership changes: the latest reported is Ron Philip, Director (Form 8-K filed 2026-06-23). Check you are dealing with the people now in charge.
• Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Ra Capital Management, L.P. (filed 2026-08-14).

Who is behind it

Avalo Therapeutics, Inc.: incorporated in Delaware; business address in Wayne, Pennsylvania; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-14).

Officers and directors, each with the role and the filing that names them:

• Garry Neil, M.D.: Executive Officer, Director (Form D, 2024-04-09)
• June Almenoff, M.D., Ph.D.: Director (Form D, 2024-04-09)
• Mitchell Chan: Director (Form D, 2024-04-09)
• Jonathan Goldman, M.D.: Director (Form D, 2024-04-09)
• Aaron Kantoff: Director (Form D, 2024-04-09)
• Gilla Kaplan, Ph.D.: Director (Form D, 2024-04-09)
• Magnus Persson, M.D., Ph.D.: Director (Form D, 2024-04-09)
• Samantha Truex: Director (Form D, 2024-04-09)
• Christopher Sullivan: Executive Officer (Form D, 2024-04-09)

Money raised

Related pages

Leadership changes5%+ holders

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

All companies

Not for employment, credit, insurance or tenancy decisions.